Incyte (INCY) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.15% |
| Dec 31, 2025 | -22.21% |
| Sep 30, 2025 | -20.98% |
| Jun 30, 2025 | -0.54% |
| Mar 31, 2025 | -11.61% |
| Dec 31, 2024 | -65.06% |
| Sep 30, 2024 | 9.80% |
| Jun 30, 2024 | 62.36% |
| Mar 31, 2024 | -5.32% |
| Dec 31, 2023 | -3.97% |
| Sep 30, 2023 | -2.72% |
| Jun 30, 2023 | -9.98% |
| Mar 31, 2023 | 3.90% |
| Dec 31, 2022 | -8.80% |
| Sep 30, 2022 | -9.36% |
| Jun 30, 2022 | -7.01% |
| Mar 31, 2022 | -8.35% |
| Dec 31, 2021 | -2.81% |
| Sep 30, 2021 | -9.76% |
| Jun 30, 2021 | -6.04% |
| Mar 31, 2021 | -8.94% |
| Dec 31, 2020 | -3.84% |
| Sep 30, 2020 | -9.14% |
| Jun 30, 2020 | -22.02% |
| Mar 31, 2020 | 38.49% |
| Jun 30, 2019 | -7.26% |
| Mar 31, 2019 | -9.92% |
| Dec 31, 2018 | -4.58% |
| Sep 30, 2018 | -339.31% |
| Jun 30, 2018 | 4.82% |
| Mar 31, 2018 | 71.88% |
| Dec 31, 2017 | 8.72% |
| Sep 30, 2017 | -110.54% |
| Jun 30, 2017 | -18.88% |
| Mar 31, 2017 | 36.68% |
| Dec 31, 2016 | -39.38% |
| Sep 30, 2016 | -18.96% |
| Jun 30, 2016 | 39.84% |
| Mar 31, 2016 | -14.54% |
| Dec 31, 2015 | -58.58% |
| Sep 30, 2015 | -1.39% |
| Jun 30, 2015 | -4.23% |
| Mar 31, 2015 | 6.73% |
| Dec 31, 2014 | -18.38% |
| Sep 30, 2014 | 24.82% |
| Jun 30, 2014 | -16.36% |
| Mar 31, 2014 | 7.36% |
| Dec 31, 2013 | -62.08% |
| Sep 30, 2013 | -4.95% |
| Jun 30, 2013 | -2.69% |
| Mar 31, 2013 | -18.28% |
| Dec 31, 2012 | 6.23% |
| Sep 30, 2012 | 6.95% |
| Jun 30, 2012 | -10.74% |
| Mar 31, 2012 | 14.84% |
| Dec 31, 2011 | 12.42% |
| Sep 30, 2011 | 12.95% |
| Jun 30, 2011 | 5.09% |
| Mar 31, 2011 | 9.56% |
| Dec 31, 2010 | -9.10% |
| Sep 30, 2010 | 6.11% |
| Jun 30, 2010 | -2.31% |